These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37283248)

  • 1. Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells.
    Boulet MHC; Bolland HR; Hammond EM; Sedgwick AC
    J Am Chem Soc; 2023 Jun; 145(24):12998-13002. PubMed ID: 37283248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.
    Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavin-Conjugated Pt(IV) Anticancer Agents.
    Sánchez-Camacho J; Infante-Tadeo S; Carrasco AC; Scoditti S; Martínez Á; Barroso-Bujans F; Sicilia E; Pizarro AM; Salassa L
    Inorg Chem; 2023 Apr; 62(14):5644-5651. PubMed ID: 36990656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.
    Henke H; Kryeziu K; Banfić J; Theiner S; Körner W; Brüggemann O; Berger W; Keppler BK; Heffeter P; Teasdale I
    Macromol Biosci; 2016 Aug; 16(8):1239-1249. PubMed ID: 27169668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Chlorambucil-Platinum(IV) Prodrugs.
    Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFR
    Li R; Zhao W; Jin C; Xiong H
    Bioorg Chem; 2023 Jun; 135():106499. PubMed ID: 37058978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis.
    Liu Z; Cai J; Jiang G; Wang M; Wu C; Su K; Hu W; Huang Y; Yu C; Huang X; Cao G; Wang H
    Eur J Med Chem; 2024 Jan; 263():115968. PubMed ID: 37995563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum (IV) drugs with cannabidiol inducing mitochondrial dysfunction and synergistically enhancing anti-tumor effects.
    Wei T; Chen L; Shi P; Wang C; Peng Y; Yang J; Liao X; Yang B; Gao C
    J Inorg Biochem; 2024 May; 254():112515. PubMed ID: 38490045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z; Wang Z; Yiu SM; Zhu G
    Dalton Trans; 2015 Dec; 44(46):19918-26. PubMed ID: 26514681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
    Wang Z; Deng Z; Zhu G
    Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.
    Göschl S; Schreiber-Brynzak E; Pichler V; Cseh K; Heffeter P; Jungwirth U; Jakupec MA; Berger W; Keppler BK
    Metallomics; 2017 Mar; 9(3):309-322. PubMed ID: 28205649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
    Wang H; Yang X; Zhao C; Wang PG; Wang X
    Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
    Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
    Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes.
    Kastner A; Schueffl H; Yassemipour PA; Keppler BK; Heffeter P; Kowol CR
    Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202311468. PubMed ID: 37703130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
    Chen F; Qin X; Xu G; Gou S; Jin X
    Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.